Home/ Supplements/ Vitamin K/ Vitamin K-2 Mena Q7

Vitamin K-2 Mena Q7

product on market Softgel Capsule DC Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is researched for its role in supporting bone health and cardiovascular function by regulating calcium deposition. There is moderate evidence suggesting it helps maintain arterial elasticity and bone density. However, overall evidence coverage for this specific profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K-2 Mena Q7
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mcg (63% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Sunflower Seed Oil Gelatin Glycerin natural Caramel color
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, adults take 1 softgel daily, preferably with a meal.

Warnings & Precautions

Tamper Evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Keep out of reach of children.

Caution: If you are pregnant or nursing do not take this product.

Contains soy ingredients.

Warning: Do not use if taking anti-coagulant drugs (blood thinners) such as Warfarin.

Formulation Notes

Vitamin K-2, also known as Menaquinone, supports normal blood clotting and plays an important role in maintaining bone health and cardiovascular health. This K-2 supplement is a trademarked variety of Vitamin K called MenaQ7 - a natural form of Vitamin K that is bioactive and extracted from a natural whole food source like soy, or fermented soy known as natto.

Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs) Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.

Gluten free

MK-7

Plays an important role in maintaining bone and cardiovascular health

Made in USA

Additional Information

Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).

Quali Pure

Metadata

Product Details

DSLD Entry Date2022-02-23
Product TypeVitamin
FormSoftgel Capsule
BrandDC
DSLD ID266427
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K-2
GNC Preventive Nutrition · Softgel Capsule
100
Vitamin K-2
NewtonEverett · Softgel Capsule
100
Low-Dose Vitamin K2 45 mcg
Life Extension · Softgel Capsule
100
Natural Vitamin K-2 Bioactive Form
Vitamin World · Softgel Capsule
100
Vitamin K2 50 mcg
Vitacost · Softgel Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from DC View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.